Breyer Capital leads $25 million round for AI/cancer research startup
February 05, 2018 at 15:00 PM EST
The company, whose name is derived from the acronym "Pathology AI Guidance Engine," was launched through Manhattan-based Memorial Sloan Kettering Cancer.
